Related Experiment Video
Updated: Jan 21, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Endovascular repair during complex thoracic aortic dissection using a micropore stent graft: Midterm follow-up
Zhe Wang1, Cheng Wang1, Fenghe Li1
1Department of Vascular Surgery, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective:
This study explored the clinical efficacy and hemodynamic effects of the micropore stent graft (MSG) that could promote aortic remodeling and preserve important organ branches.
Methods:
We conducted a retrospective analysis of 26 patients who underwent endovascular repair using an MSG for DeBakey types I and III TAD at our center between December 2014 and December 2017. The main efficacy parameters were rupture of the false lumen or dissection-related death, conversion to open repair, secondary reintervention, branch vessel patency, and the hemodynamic effects of TAD at 12 months.
Results:
Dissection rupture, dissection-related mortality, conversion to open repair, and secondary reintervention rates at 12 months were 0, 3.9, 0, and 0%, respectively. In the 24 patients with more than 6 months of follow-up, micropore stents were implanted to cover 39 openings in aortic arch branches, 91.7% (22/24) presented with complete thrombosis in the false lumen, 8.3% (2/24) presented with partial thrombosis in the false lumen, 35.2% (6/17) presented with a thrombus in the false lumen that was completely absorbed, and all 39 branches were patent. After surgery, pressure peak value and fluctuation along with the degree and range of unstable blood flow in the aortic lumen decreased.
Conclusions:
For type I and type III thoracic artic dissection, endovascular treatment with an MSG may be a safe and effective treatment option with a good midterm outcome.
Insights
Micropore stent grafts (MSG) offer a safe and effective endovascular repair for thoracic aortic dissection (TAD), demonstrating excellent midterm outcomes. This approach promotes aortic remodeling and preserves vital organ branches with no major adverse events reported.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Vascular Biology
Background:
- Thoracic aortic dissection (TAD) poses significant risks.
- Endovascular repair aims to improve outcomes and minimize invasiveness.
- Aortic remodeling and branch vessel preservation are key challenges in TAD treatment.
Purpose of the Study:
- To evaluate the clinical efficacy and hemodynamic effects of micropore stent grafts (MSG) in patients with DeBakey types I and III TAD.
- To assess the potential of MSG to promote aortic remodeling and preserve organ branches.
Main Methods:
- Retrospective analysis of 26 patients with DeBakey types I and III TAD treated with MSG.
- Follow-up included assessment of rupture, mortality, reintervention, branch patency, and hemodynamic effects at 12 months.
Main Results:
- Zero rates for dissection rupture, conversion to open repair, and secondary reintervention at 12 months.
- High rates of false lumen thrombosis (91.7% complete, 8.3% partial) and 100% branch vessel patency.
- Post-operative reduction in aortic lumen pressure fluctuations and unstable blood flow.
Conclusions:
- Endovascular treatment with MSG is a safe and effective option for DeBakey type I and III TAD.
- MSG demonstrates good midterm outcomes, including aortic remodeling and branch vessel preservation.
- Hemodynamic improvements suggest favorable aortic lumen conditions post-treatment.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Nucleotide Excision Repair
Mismatch Repair
Thoracic Aorta
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...

